How is the Clearside Biomedical Inc today?

The Clearside Biomedical Inc today is trading in the down by -1.23% at 0.80.

How has Clearside Biomedical Inc performed historically?

The Clearside Biomedical Inc is currently trading down -1.23% on an intraday basis in the past week the index rose 1.27%. The index has been down -6.98% in the past quarter and fell -34.96% in the past year. You can view this in the overview section.

What is Clearside Biomedical Inc Annual Revenue?

Clearside Biomedical Inc Annual Revenue fell 79.77%, in the last year to $1.66 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Clearside Biomedical Inc Annual Net Profit?

Clearside Biomedical Inc Annual Net Profit fell 5.75% in the last year to $34.35 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Clearside Biomedical Inc Price to Earning Ratio?

Clearside Biomedical Inc Price to Earning Ratio is -2.02, which is negative.

What is Clearside Biomedical Inc Stock Price?

Clearside Biomedical Inc Stock Price fell 34.96% and underperformed its sector by 59.77% in the past year.

What is Clearside Biomedical Inc Quarterly Revenue?

Clearside Biomedical Inc Quarterly Revenue rose 913.04% YoY to $2.33 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Clearside Biomedical Inc Quarterly Net profit?

Clearside Biomedical Inc Quarterly Net profit rose 30.09% YoY to $8.22 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is Clearside Biomedical Inc Mutual Fund Holding?

Clearside Biomedical Inc Mutual Fund Holding decreased by 0.25% in the last quarter to 11.79.

What is Clearside Biomedical Inc Promoter Share Holding?

Clearside Biomedical Inc Promoter Share Holding stayed the same in the most recent quarter at 2.09%.

What is Clearside Biomedical Inc Interest Coverage Ratio?

Clearside Biomedical Inc Interest Coverage Ratio is -2.51, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Clearside Biomedical Inc Institutional Holding?

Clearside Biomedical Inc Institutional Holding decreased by 0.76% in the last quarter to 11.54.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
CLEARSIDE BIOMEDICAL INC

Clearside Biomedical Inc XNAS: CLSD

Clearside Biomedical Inc Live Share Price Today, Share Analysis and Chart

Name: Clearside Biomedical Inc: Is Infosys Ltd. worth buying?
Item: Clearside Biomedical Inc
Rating: 1.11783325
Author: Trendlyne DVM scores

about

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injecti...

0.80 -0.01 (-1.23%)

51.52% Fall from 52W High

186.8K

XNAS Volume

High vol. this week

XNAS 13 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Clearside Biomedical Inc is on 20 Jun 2025 for the purpose of Clearside Biomedical Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

4.8 / 100

Technically Neutral

39.9 / 100

1Yr Price target upside is 579%

7 analysts

Clearside Biomedical Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Clearside Biomedical Inc Live Share Price Today, Share Analysis and Chart

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injecti...

51.52% Fall from 52W High

High vol. this week

SWOT Analysis

Clearside Biomedical Inc Live Price Chart

Clearside Biomedical Inc FAQ

How is Clearside Biomedical Inc today?

Clearside Biomedical Inc today is trading in the red, and is down by -1.23% at 0.80.

How has Clearside Biomedical Inc performed historically?

Clearside Biomedical Inc is currently trading down -1.23% on an intraday basis. In the past week the stock rose 1.27%. stock has been down -6.98% in the past quarter and fell -34.96% in the past year. You can view this in the overview section.